These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 29035118)

  • 1. Clinical Gene Therapy for Neurodegenerative Diseases: Past, Present, and Future.
    Piguet F; Alves S; Cartier N
    Hum Gene Ther; 2017 Nov; 28(11):988-1003. PubMed ID: 29035118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adeno-associated viral gene delivery in neurodegenerative disease.
    Morgenstern PF; Marongiu R; Musatov SA; Kaplitt MG
    Methods Mol Biol; 2011; 793():443-55. PubMed ID: 21913118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapeutic strategies for neurodegenerative diseases.
    Baekelandt V; De Strooper B; Nuttin B; Debyser Z
    Curr Opin Mol Ther; 2000 Oct; 2(5):540-54. PubMed ID: 11249757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voyager's CNS gene therapy.
    Nat Biotechnol; 2019 Mar; 37(3):204. PubMed ID: 30833767
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting Age-Related Neurodegenerative Diseases by AAV-Mediated Gene Therapy.
    Cagin U
    Adv Exp Med Biol; 2021; 1286():213-223. PubMed ID: 33725356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and Advances in Gene Therapy Approaches for Neurodegenerative Disorders.
    Donde A; Wong PC; Chen LL
    Curr Gene Ther; 2017; 17(3):187-193. PubMed ID: 29034834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery.
    Joshi CR; Labhasetwar V; Ghorpade A
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):51-83. PubMed ID: 28160121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders.
    Mandel RJ; Manfredsson FP; Foust KD; Rising A; Reimsnider S; Nash K; Burger C
    Mol Ther; 2006 Mar; 13(3):463-83. PubMed ID: 16412695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CNS diseases amenable to gene therapy.
    Federoff HJ
    Ernst Schering Res Found Workshop; 2003; (43):117-58. PubMed ID: 12894455
    [No Abstract]   [Full Text] [Related]  

  • 10. Applications of adeno-associated virus vector-mediated gene delivery for neurodegenerative diseases and psychiatric diseases: Progress, advances, and challenges.
    Abulimiti A; Lai MS; Chang RC
    Mech Ageing Dev; 2021 Oct; 199():111549. PubMed ID: 34352323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perinatal gene delivery to the CNS.
    Rahim AA; Buckley SM; Chan JK; Peebles DM; Waddington SN
    Ther Deliv; 2011 Apr; 2(4):483-91. PubMed ID: 22826856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene transfer into the central and peripheral nervous system: applications for the treatment of neurodegenerative diseases and peripheral neuropathies.
    Pradat PF; Mallet J
    Biotechnol Genet Eng Rev; 2003; 20():49-76. PubMed ID: 14997846
    [No Abstract]   [Full Text] [Related]  

  • 13. Parkinson's disease: gene therapies.
    Coune PG; Schneider BL; Aebischer P
    Cold Spring Harb Perspect Med; 2012 Apr; 2(4):a009431. PubMed ID: 22474617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing neurotrophic factors as treatments for age-related neurodegenerative diseases: developing and demonstrating "clinical proof-of-concept" for AAV-neurturin (CERE-120) in Parkinson's disease.
    Bartus RT; Baumann TL; Brown L; Kruegel BR; Ostrove JM; Herzog CD
    Neurobiol Aging; 2013 Jan; 34(1):35-61. PubMed ID: 22926166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges.
    Kang L; Jin S; Wang J; Lv Z; Xin C; Tan C; Zhao M; Wang L; Liu J
    J Control Release; 2023 Mar; 355():458-473. PubMed ID: 36736907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodegenerative Disorders Treatment: The MicroRNA Role.
    Ridolfi B; Abdel-Haq H
    Curr Gene Ther; 2017; 17(5):327-363. PubMed ID: 29357791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adeno-associated virus-mediated gene delivery approaches for the treatment of CNS disorders.
    Terzi D; Zachariou V
    Biotechnol J; 2008 Dec; 3(12):1555-63. PubMed ID: 19072910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the Role of Gene Therapy for Neurological Disorders.
    Puranik N; Yadav D; Chauhan PS; Kwak M; Jin JO
    Curr Gene Ther; 2021; 21(1):11-22. PubMed ID: 32940177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy of the central nervous system: general considerations on viral vectors for gene transfer into the brain.
    Serguera C; Bemelmans AP
    Rev Neurol (Paris); 2014 Dec; 170(12):727-38. PubMed ID: 25459120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-Generation Gene Therapy for Parkinson's Disease Using Engineered Viral Vectors.
    Björklund T; Davidsson M
    J Parkinsons Dis; 2021; 11(s2):S209-S217. PubMed ID: 34366370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.